- Atherectomy systems, providing essential tools for removing plaque from arteries during minimally invasive cardiovascular procedures, are increasingly critical components of modern healthcare settings, including hospitals, specialty clinics, and ambulatory surgical centers, due to their vital role in ensuring patient safety and effective treatment of arterial diseases
- The escalating demand for atherectomy systems is primarily fueled by the growing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), the increasing number of interventional procedures, and the rising need for effective plaque removal in complex arterial lesions
- North America dominates the atherectomy systems market with the largest revenue share of 42.7% in 2024, characterized by advanced healthcare infrastructure, high adoption rates of sophisticated medical devices, and a strong presence of leading medical device manufacturers
- Asia-Pacific is expected to be the fastest-growing region in the atherectomy systems market during the forecast period, with an anticipated CAGR of 9.5%, due to increasing healthcare expenditure, a growing aging population susceptible to cardiovascular ailments, and rising awareness of advanced atherectomy techniques in rapidly developing healthcare systems
- Orbital atherectomy devices segment dominates the largest market revenue share of 34.1% in 2024, driven by its effectiveness in treating calcified lesions and its ability to prepare vessels for optimal stent placement, making it a preferred choice among clinicians for a wide range of arterial interventions
